Feasibility and Effectiveness of HPV Self-Sampling for Cervical Cancer Screening Among Women Seeking Health Care At a Safety Net Hospital Emergency Room
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Baylor College of Medicine
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- HPV self-sampling completion
Study Overview
Brief Summary
The goal of this study is to develop and evaluate an evidence-based public health intervention using HPV self-sampling approach in an opportunistic setting to increase cervical cancer screening among screening non-attendees, particularly those uninsured or underinsured, who use emergency services to access medical care. The proposed pilot study will examine the feasibility and efficacy of HPV self-sampling among women at a safety net hospital emergency room. Participant recruitment and self-sample will take place in the waiting rooms in the ER. All women sitting in the waiting room will serve as the source population for the study and will be approached and invited to participate in the study.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 25 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Eligible participants are women ages 25 years to 65 years, with a cervix, presenting in the waiting areas at the Ben Taub General Hospital Emergency Department
Exclusion Criteria
- •Women under 25 years or older than 65 years of age,
- •self-reported current pregnancy,
- •self-reported history of cervical cancer,
- •past hysterectomy,
- •had Pap Smear within past 3 years or HPV/Pap co-test within past 5 years.
Outcomes
Primary Outcomes
HPV self-sampling completion
Time Frame: 1 day
Participation rate for self-sample HPV testing (percent of eligible women who complete self-sampling).
Secondary Outcomes
- HPV self-sampling acceptability(1 day)
- Attendance for cervical cancer screening among HR-HPV positive women(6 months)
Investigators
Aaron Peter Thrift
Associate Professor
Baylor College of Medicine